0000908662-15-000288.txt : 20150811 0000908662-15-000288.hdr.sgml : 20150811 20150811162902 ACCESSION NUMBER: 0000908662-15-000288 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150807 FILED AS OF DATE: 20150811 DATE AS OF CHANGE: 20150811 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYAX CORP CENTRAL INDEX KEY: 0000907562 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043053198 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 55 NETWORK DRIVE CITY: BURLINGTON STATE: MA ZIP: 01803-2756 BUSINESS PHONE: 617-250-5769 MAIL ADDRESS: STREET 1: 55 NETWORK DRIVE CITY: BURLINGTON STATE: MA ZIP: 01803-2756 FORMER COMPANY: FORMER CONFORMED NAME: BIOTAGE INC DATE OF NAME CHANGE: 19951117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KEMPNER THOMAS L CENTRAL INDEX KEY: 0001091925 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24537 FILM NUMBER: 151044197 MAIL ADDRESS: STREET 1: C/O LOEB PARTNERS CORPORATION STREET 2: 125 BROAD STREET, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10004 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-08-07 0000907562 DYAX CORP DYAX 0001091925 KEMPNER THOMAS L C/O DYAX CORP. 55 NETWORK DRIVE BURLINGTON MA 01803-2756 1 0 0 0 Common Stock 2015-08-07 4 S 0 18600 23.8028 D 0 I By Loeb Investors Co. IX Common Stock 2015-08-07 4 S 0 37200 23.8028 D 577120 I By Loeb Holding Corporation Common Stock 2015-08-07 4 S 0 37200 23.8028 D 1034651 I By Trust Common Stock 2015-08-10 4 S 0 25000 23.8426 D 1009651 I By Trust Common Stock 2015-08-11 4 S 0 2800 23.8839 D 1006851 I By Trust Common Stock 5021 I By Spouse Common Stock 55041 D The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $23.57 to $23.895, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1. The reporting person is the Managing Partner of Loeb Investors Co. IX. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. The reporting person is the Chairman, Chief Executive Officer, and also beneficial owner of a majority of the voting stock of Loeb Holding Corporation. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Shares held in trust, of which the reporting person is the trustee, for the benefit of the reporting person's brother's children, the reporting person's children, the reporting person's sister-in-law, and the reporting person. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $23.80 to $23.925, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 5. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $23.80 to $23.96, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 6. /s/ Stacie S. Aarestad, as attorney-in-fact 2015-08-11